If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ATTORA LA methylphenidate hydrochloride 40 mg modified release capsule bottle AUST R: 408178Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, modified release
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800195055
|
From
08 Oct 2026
to
27 Nov 2026
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
An alternative brand is available.
|
RUBIFEN LA methylphenidate hydrochloride 40 mg modified release capsules blister pack AUST R: 362230Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
13 May 2025
to
31 Oct 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
RUBIFEN LA methylphenidate hydrochloride 60 mg modified release capsules blister pack AUST R: 362234Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
18 Apr 2025
to
31 Oct 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
ATTORA LA methylphenidate hydrochloride 60 mg modified release capsule bottle AUST R: 408174Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, modified release
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800195055
|
From
13 Nov 2026
to
27 Nov 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
An alternative brand is available.
|
RUBIFEN LA methylphenidate hydrochloride 10 mg modified release capsules blister pack AUST R: 362233Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
03 Jun 2025
to
20 Aug 2026
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
RUBIFEN LA methylphenidate hydrochloride 20 mg modified release capsules blister pack AUST R: 362231Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
25 Aug 2025
to
20 Aug 2026
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack AUST R: 362232Active ingredients:
methylphenidate hydrochloride
Dosage form:
Capsule, hard
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
From
10 Jun 2025
to
01 Oct 2026
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in demand due to other sponsors unable to supply
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 18 mg modified release tablet bottle AUST R: 370912Active ingredients:
methylphenidate hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
25 Nov 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 27 mg modified release tablet bottle AUST R: 370911Active ingredients:
methylphenidate hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
30 Jan 2027
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 36 mg modified release tablet bottle AUST R: 370900Active ingredients:
methylphenidate hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
25 Sep 2026
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle AUST R: 370899Active ingredients:
methylphenidate hydrochloride
Dosage form:
Tablet, modified release
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
25 Sep 2026
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
|